Serum brain-derived neurotrophic factor levels in different neurological diseases

BioMed Research International

Volumn 2013, Issue , 2013, Pages

  Ventriglia, Mariacarla ^a   Zanardini, Roberta ^a   Bonomini, Cristina ^a   Zanetti, Orazio ^a   Volpe, Daniele ^b   Pasqualetti, Patrizio ^a   Gennarelli, Massimo ^a,c   Bocchio Chiavetto, Luisella ^a  

^a IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^b AFaR Ospedale S Raffaele Arcangelo Fatebenefratelli   (Italy)

^c UNIVERSITY OF BRESCIA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; BENZODIAZEPINE DERIVATIVE; BRAIN DERIVED NEUROTROPHIC FACTOR; CHOLINESTERASE INHIBITOR; LEVODOPA; MOOD STABILIZER; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; DIFFUSE LEWY BODY DISEASE; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTIINFARCT DEMENTIA; NEUROLOGIC DISEASE; PROTEIN BLOOD LEVEL; AGED; ALZHEIMER DISEASE; BLOOD; MIDDLE AGED; PARKINSON DISEASE; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTICONVULSANTS; BENZODIAZEPINES; BRAIN-DERIVED NEUROTROPHIC FACTOR; DEMENTIA, VASCULAR; FEMALE; FRONTOTEMPORAL DEMENTIA; HUMANS; LEWY BODY DISEASE; MALE; MIDDLE AGED; PARKINSON DISEASE;

EID: 84884277445     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2013/901082     Document Type: Article

References (60)

1. Genius J., Klafki H., Benninghoff J., Esselmann H., Wiltfang J., Current application of neurochemical biomarkers in the prediction and differential diagnosis of Alzheimer's disease and other neurodegenerative dementias. European Archives of Psychiatry and Clinical Neuroscience 2012 262 2 71 77 10.1007/s00406-012-0362-3
2. Balaratnasingam S., Janca A., Brain derived neurotrophic factor: a novel neurotrophin involved in psychiatric and neurological disorders. Pharmacology and Therapeutics 2012 134 1 116 124 2-s2.0-84857363735 10.1016/j.pharmthera. 2012.01.006
3. Arancio O., Chao M. V., Neurotrophins, synaptic plasticity and dementia. Current Opinion in Neurobiology 2007 17 3 325 330 2-s2.0-34249932508 10.1016/j.conb.2007.03.013
4. Zuccato C., Cattaneo E., Brain-derived neurotrophic factor in neurodegenerative diseases. Nature Reviews Neurology 2009 5 6 311 322 2-s2.0-68849083063 10.1038/nrneurol.2009.54
5. Diniz B. S., Teixeira A. L., Brain-derived neurotrophic factor and Alzheimer's disease: physiopathology and beyond. NeuroMolecular Medicine 2011 13 4 217 222 2-s2.0-84855904096 10.1007/s12017-011-8154-x
6. Murer M. G., Yan Q., Raisman-Vozari R., Brain-derived neurotrophic factor in the control human brain, and in Alzheimer's disease and Parkinson's disease. Progress in Neurobiology 2001 63 1 71 124 2-s2.0-0035239020 10.1016/S0301-0082(00)00014-9
7. Peng S., Wuu J., Mufson E. J., Fahnestock M., Precursor form of brain-derived neurotrophic factor and mature brain-derived neurotrophic factor are decreased in the pre-clinical stages of Alzheimer's disease. Journal of Neurochemistry 2005 93 6 1412 1421 2-s2.0-20744434559 10.1111/j.1471-4159.2005. 03135.x
8. Imamura K., Hishikawa N., Ono K., Suzuki H., Sawada M., Nagatsu T., Yoshida M., Hashizume Y., Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains. Acta Neuropathologica 2005 109 2 141 150 2-s2.0-16344382456 10.1007/s00401-004-0919-y
9. Ferrer I., Marín C., Rey M. J., Ribalta T., Brain-derived neurotrophic factor in patients with frontotemporal dementia. Neuroscience Letters 2000 279 1 33 36 2-s2.0-0033976189 10.1016/S0304-3940(99)00937-4
10. Mattson M. P., Glutamate and neurotrophic factors in neuronal plasticity and disease. Annals of the New York Academy of Sciences 2008 1144 97 112 2-s2.0-56649124807 10.1196/annals.1418.005
11. Murer M. G., Boissiere F., Yan Q., Hunot S., Villares J., Faucheux B., Agid Y., Hirsch E., Raisman-Vozari R., An immunohistochemical study of the distribution of brain-derived neurotrophic factor in the adult human brain, with particular reference to Alzheimer's disease. Neuroscience 1999 88 4 1015 1032 2-s2.0-0032890036 10.1016/S0306-4522(98)00219-X
12. Kohno R., Sawada H., Kawamoto Y., Uemura K., Shibasaki H., Shimohama S., BDNF is induced by wild-type α -synuclein but not by the two mutants, A30P or A53T, in glioma cell line. Biochemical and Biophysical Research Communications 2004 318 1 113 118 2-s2.0-1942456752 10.1016/j.bbrc.2004.04.012
13. Fujimura H., Altar C. A., Chen R., Nakamura T., Nakahashi T., Kambayashi J.-I., Sun B., Tandon N. N., Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thrombosis and Haemostasis 2002 87 4 728 734 2-s2.0-0036214689
14. Gielen A., Khademi M., Muhallab S., Olsson T., Piehl F., Increased brain-derived neurotrophic factor expression in white blood cells of relapsing-remitting multiple sclerosis patients. Scandinavian Journal of Immunology 2003 57 5 493 497 2-s2.0-0037616364 10.1046/j.1365-3083.2003.01260.x
15. Nakahashi T., Fujimura H., Altar C. A., Li J., Kambayashi J.-I., Tandon N. N., Sun B., Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Letters 2000 470 2 113 117 2-s2.0-0034708618 10.1016/S0014-5793(00)01302-8
16. Cattaneo A., Bocchio-Chiavetto L., Zanardini R., Milanesi E., Placentino A., Gennarelli M., Reduced peripheral brain-derived neurotrophic factor mRNA levels are normalized by antidepressant treatment. International Journal of Neuropsychopharmacology 2010 13 1 103 108 2-s2.0-77949658730 10.1017/S1461145709990812
17. Pan W., Banks W. A., Fasold M. B., Bluth J., Kastin A. J., Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 1998 37 12 1553 1561 2-s2.0-0032404127 10.1016/S0028-3908(98) 00141-5
18. Poduslo J. F., Curran G. L., Permeability at the blood-brain and blood-nerve barriers of the neurotrophic factors: NGF, CNTF, NT-3, BDNF. Molecular Brain Research 1996 36 2 280 286 2-s2.0-0029928170 10.1016/0169-328X(95)00250-V
19. Bocchio-Chiavetto L., Bagnardi V., Zanardini R., Molteni R., Gabriela Nielsen M., Placentino A., Giovannini C., Rillosi L., Ventriglia M., Riva M. A., Gennarelli M., Serum and plasma BDNF levels in major depression: a replication study and meta-analyses. World Journal of Biological Psychiatry 2010 11 6 763 773 2-s2.0-77955637265 10.3109/15622971003611319
20. Castrén E., Rantamäki T., The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity. Developmental Neurobiology 2010 70 5 289 297 10.1002/dneu.20758
21. Lang U. E., Hellweg R., Seifert F., Schubert F., Gallinat J., Correlation between serum brain-derived neurotrophic factor level and an in vivo marker of cortical integrity. Biological Psychiatry 2007 62 5 530 535 2-s2.0-34548028287 10.1016/j.biopsych.2007.01.002
22. Gunstad J., Benitez A., Smith J., Glickman E., Spitznagel M. B., Alexander T., Juvancic-Heltzel J., Murray L., Serum brain-derived neurotrophic factor is associated with cognitive function in healthy older adults. Journal of Geriatric Psychiatry and Neurology 2008 21 3 166 170 2-s2.0-49749131573 10.1177/0891988708316860
23. Laske C., Stransky E., Leyhe T., Eschweiler G. W., Maetzler W., Wittorf A., Soekadar S., Richartz E., Koehler N., Bartels M., Buchkremer G., Schott K., BDNF serum and CSF concentrations in Alzheimer's disease, normal pressure hydrocephalus and healthy controls. Journal of Psychiatric Research 2007 41 5 387 394 2-s2.0-33846640660 10.1016/j.jpsychires.2006.01.014
24. Forlenza O. V., Diniz B. S., Teixeira A. L., Ojopi E. B., Talib L. L., Mendonça V. A., Izzo G., Gattaz W. F., Effect of brain-derived neurotrophic factor Val66Met polymorphism and serum levels on the progression of mild cognitive impairment. World Journal of Biological Psychiatry 2010 11 6 774 780 2-s2.0-77955635771 10.3109/15622971003797241
25. Jung G. L., Bae S. S., Young S. Y., Ji E. K., Sung W. Y., Dong W. J., Jun H. B., Sung W. P., Young H. K., Decreased serum brain-derived neurotrophic factor levels in elderly Korean with dementia. Psychiatry Investigation 2009 6 4 299 305 2-s2.0-75649087374 10.4306/pi.2009.6.4.299
26. Scalzo P., Kümmer A., Bretas T. L., Cardoso F., Teixeira A. L., Serum levels of brain-derived neurotrophic factor correlate with motor impairment in Parkinson's disease. Journal of Neurology 2010 257 4 540 545 2-s2.0-77951255298 10.1007/s00415-009-5357-2
27. Angelucci F., Oliviero A., Pilato F., Saturno E., Dileone M., Versace V., Musumeci G., Batocchi A. P., Tonali P. A., Di Lazzaro V., Transcranial magnetic stimulation and BDNF plasma levels in amyotrophic lateral sclerosis. NeuroReport 2004 15 4 717 720 2-s2.0-11144358551 10.1097/00001756-200403220- 00029
28. O'Bryant S. E., Hobson V. L., Hall J. R., Barber R. C., Zhang S., Johnson L., Diaz-Arrastia R., Serum brain-derived neurotrophic factor levels are specifically associated with memory performance among Alzheimer's disease cases. Dementia and Geriatric Cognitive Disorders 2011 31 1 31 36 2-s2.0-78649694939 10.1159/000321980
29. Yasutake C., Kuroda K., Yanagawa T., Okamura T., Yoneda H., Serum BDNF, TNF- α and IL-1 β levels in dementia patients: comparison between Alzheimer's disease and vascular dementia. European Archives of Psychiatry and Clinical Neuroscience 2006 256 7 402 406 2-s2.0-33750049661 10.1007/s00406-006- 0652-8
30. Leyhe T., Eschweiler G. W., Stransky E., Gasser T., Annas P., Basun H., Laske C., Increase of BDNF serum concentration in lithium treated patients with early alzheimer's disease. Journal of Alzheimer's Disease 2009 16 3 649 656 2-s2.0-65549090537 10.3233/JAD-2009-1004
31. Zhang X., Andren P. E., Svenningsson P., Repeated l-DOPA treatment increases c-fos and BDNF mRNAs in the subthalamic nucleus in the 6-OHDA rat model of Parkinson's disease. Brain Research 2006 1095 1 207 210 2-s2.0-33745000075 10.1016/j.brainres.2006.04.019
32. Sen S., Duman R., Sanacora G., Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and Implications. Biological Psychiatry 2008 64 6 527 532 2-s2.0-49749101642 10.1016/j.biopsych. 2008.05.005
33. Ricci V., Pomponi M., Martinotti G., Bentivoglio A., Loria G., Bernardini S., Caltagirone C., Bria P., Angelucci F., Antidepressant treatment restores brain-derived neurotrophic factor serum levels and ameliorates motor function in parkinson disease patients. Journal of Clinical Psychopharmacology 2010 30 6 751 753 2-s2.0-78649357002 10.1097/JCP.0b013e3181fc2ec7
34. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M., Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 1984 34 7 939 944 2-s2.0-0021271971
35. American Psychiatric Association, Diagnostic and Statistical Manual of Mental Disorders 2000 4th Washington, DC, USA Text Revision
36. Neary D., Snowden J. S., Gustafson L., Passant U., Stuss D., Black S., Freedman M., Kertesz A., Robert P. H., Albert M., Boone K., Miller B. L., Cummings J., Benson D. F., Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 1998 51 6 1546 1554 2-s2.0-0031672540
37. McKeith I. G., Dickson D. W., Lowe J., Emre M., O'Brien J. T., Feldman H., Cummings J., Duda J. E., Lippa C., Perry E. K., Aarsland D., Arai H., Ballard C. G., Boeve B., Burn D. J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C. G., Gomez-Tortosa E., Halliday G., Hansen L. A., Hardy J., Iwatsubo T., Kalaria R. N., Kaufer D., Kenny R. A., Korczyn A., Kosaka K., Lee V. M. Y., Lees A., Litvan I., Londos E., Lopez O. L., Minoshima S., Mizuno Y., Molina J. A., Mukaetova-Ladinska E. B., Pasquier F., Perry R. H., Schulz J. B., Trojanowski J. Q., Yamada M., Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 2005 65 12 1863 1872 2-s2.0-33144489150 10.1212/01.wnl.0000187889.17253.b1
38. Román G. C., Tatemichi T. K., Erkinjuntti T., Cummings J. L., Masdeu J. C., Garcia J. H., Amaducci L., Orgogozo J.-M., Brun A., Hofman A., Moody D. M., O'Brien M. D., Yamaguchi T., Grafman J., Drayer B. P., Bennett D. A., Fisher M., Ogata J., Kokmen E., Vascular dementia: diagnostic criteria for research studies: report of the NINDS-AIREN International Workshop. Neurology 1993 43 2 250 260 2-s2.0-0027534657
39. Emre M., Aarsland D., Brown R., Burn D. J., Duyckaerts C., Mizuno Y., Broe G. A., Cummings J., Dickson D. W., Gauthier S., Goldman J., Goetz C., Korczyn A., Lees A., Levy R., Litvan I., McKeith I., Olanow W., Poewe W., Quinn N., Sampaio C., Tolosa E., Dubois B., Clinical diagnostic criteria for dementia associated with Parkinson's disease. Movement Disorders 2007 22 12 1689 1707 2-s2.0-35348939603 10.1002/mds.21507
40. Folstein M. F., Folstein S. E., McHugh P. R., "Mini-mental state": a practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975 12 3 189 198 10.1016/0022-3956(75)90026-6
41. Hoehn M. M., Yahr M. D., Parkinsonism: onset, progression and mortality. Neurology 1967 17 5 427 442 2-s2.0-0014082977
42. Laske C., Stransky E., Leyhe T., Eschweiler G. W., Schott K., Langer H., Gawaz M., Decreased brain-derived neurotrophic factor (BDNF)- and β -thromboglobulin (β -TG)- blood levels in Alzheimer's disease. Thrombosis and Haemostasis 2006 96 1 102 103 2-s2.0-33746691849 10.1160/TH06-03-0173
43. Rohe M., Synowitz M., Glass R., Paul S. M., Nykjaer A., Willnow T. E., Brain-derived neurotrophic factor reduces amyloidogenic processing through control of SORLA gene expression. The Journal of Neuroscience 2009 29 49 15472 15478 2-s2.0-71849109591 10.1523/JNEUROSCI.3960-09.2009
44. Elliott E., Atlas R., Lange A., Ginzburg I., Brain-derived neurotrophic factor induces a rapid dephosphorylation of tau protein through a PI-3Kinase signalling mechanism. European Journal of Neuroscience 2005 22 5 1081 1089 2-s2.0-25844490528 10.1111/j.1460-9568.2005.04290.x
45. Ferrer I., Krupinski J., Goutan E., Martí E., Ambrosio S., Arenas E., Brain-derived neurotrophic factor reduces cortical cell death by ischemia after middle cerebral artery occlusion in the rat. Acta Neuropathologica 2001 101 3 229 238 2-s2.0-0035109207
46. Nagahara A. H., Tuszynski M. H., Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nature Reviews Drug Discovery 2011 10 3 209 219 2-s2.0-79952182383 10.1038/nrd3366
47. Teixeira A. L., Barbosa I. G., Diniz B. S., Kummer A., Circulating levels of brain-derived neurotrophic factor: correlation with mood, cognition and motor function. Biomarkers in Medicine 2010 4 6 871 887 2-s2.0-78650758486 10.2217/bmm.10.111
48. Kostrzewa R. M., Nowak P., Kostrzewa J. P., Kostrzewa R. A., Brus R., Peculiarities of L-DOPA treatment of Parkinson's disease. Amino Acids 2005 28 2 157 164 2-s2.0-17044406320 10.1007/s00726-005-0162-4
49. Zhu C. W., Livote E. E., Kahle-Wrobleski K., Scarmeas N., Albert M., Brandt J., Blacker D., Sano M., Stern Y., Utilization of antihypertensives, antidepressants, antipsychotics, and hormones in Alzheimer disease. Alzheimer Disease and Associated Disorders 2011 25 2 144 148 2-s2.0-79958255090 10.1097/WAD.0b013e3181fcba68
50. Chen B., Dowlatshahi D., MacQueen G. M., Wang J.-F., Young L. T., Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biological Psychiatry 2001 50 4 260 265 2-s2.0-0035881828 10.1016/S0006-3223(01)01083-6
51. Shimizu E., Hashimoto K., Okamura N., Koike K., Komatsu N., Kumakiri C., Nakazato M., Watanabe H., Shinoda N., Okada S.-I., Iyo M., Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry 2003 54 1 70 75 2-s2.0-0038771149 10.1016/S0006-3223(03)00181-1
52. Huopaniemi L., Keist R., Randolph A., Certa U., Rudolph U., Diazepam-induced adaptive plasticity revealed by α 1 GABAA receptor-specific expression profiling. Journal of Neurochemistry 2004 88 5 1059 1067 2-s2.0-1442323995 10.1046/j.1471-4159.2003.02216.x
53. Huang T.-L., Hung Y.-Y., Lorazepam reduces the serum brain-derived neurotrophic factor level in schizophrenia patients with catatonia. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2009 33 1 158 159 2-s2.0-58149345044 10.1016/j.pnpbp.2008.10.016
54. Canas N., Pereira I. T., Ribeiro J. A., Sebastião A. M., Brain-derived neurotrophic factor facilitates glutamate and inhibits GABA release from hippocampal synaptosomes through different mechanisms. Brain Research 2004 1016 1 72 78 2-s2.0-3042658254 10.1016/j.brainres.2004.04.070
55. Matsumoto T., Numakawa T., Yokomaku D., Adachi N., Yamagishi S., Numakawa Y., Kunugi H., Taguchi T., Brain-derived neurotrophic factor-induced potentiation of glutamate and GABA release: different dependency on signaling pathways and neuronal activity. Molecular and Cellular Neuroscience 2006 31 1 70 84 2-s2.0-30044444378 10.1016/j.mcn.2005.09.002
56. Singh B., Henneberger C., Betances D., Arevalo M. A., Rodríguez-Tébar A., Meier J. C., Grantyn R., Altered balance of glutamatergic/GABAergic synaptic input and associated changes in dendrite morphology after BDNF expression in BDNF-deficient hippocampal neurons. The Journal of Neuroscience 2006 26 27 7189 7200 2-s2.0-33746233381 10.1523/JNEUROSCI.5474-05.2006
57. Nishino S., Ohtomo K., Numata Y., Sato T., Nakahata N., Kurita M., Divergent effects of lithium and sodium valproate on brain-derived neurotrophic factor (BDNF) production in human astrocytoma cells at therapeutic concentrations. Progress in Neuro-Psychopharmacology and Biological Psychiatry 2012 39 1 17 22 10.1016/j.pnpbp.2011.07.008
58. Haymond J., Ensom M. H. H., Does valproic acid warrant therapeutic drug monitoring in bipolar affective disorder? Therapeutic Drug Monitoring 2010 32 1 19 29 2-s2.0-75649115718 10.1097/FTD.0b013e3181c13a30
59. Jornada L. K., Moretti M., Valvassori S. S., Ferreira C. L., Padilha P. T., Arent C. O., Fries G. R., Kapczinski F., Quevedo J., Effects of mood stabilizers on hippocampus and amygdala BDNF levels in an animal model of mania induced by ouabain. Journal of Psychiatric Research 2010 44 8 506 510 2-s2.0-77952891145 10.1016/j.jpsychires.2009.11.002
60. Matrisciano F., Bonaccorso S., Ricciardi A., Scaccianoce S., Panaccione I., Wang L., Ruberto A., Tatarelli R., Nicoletti F., Girardi P., Shelton R. C., Changes in BDNF serum levels in patients with major depression disorder (MDD) after 6 months treatment with sertraline, escitalopram, or venlafaxine. Journal of Psychiatric Research 2009 43 3 247 254 2-s2.0-57749205200 10.1016/j.jpsychires.2008.03.014